dr. dorff on choosing between therapies in nonmetastatic crpc
Published 5 years ago • 91 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
0:19
copy of dr. dorff on choosing between therapies in nonmetastatic crpc
-
2:02
dr. dorff on sequencing in metastatic castration-resistant prostate cancer
-
1:45
dr. choudhury on antiandrogen treatment selection in nonmetastatic crpc
-
1:24
dr. dorff discusses the use of parp inhibitors in prostate cancer
-
1:10
dr. dorff on current agents for patients with mcrpc
-
1:38
dr. dorff on role of chemotherapy in mcrpc
-
6:56
genetic testing in metastatic crpc
-
5:55
the future of treatment for nonmetastatic crpc
-
6:03
approaching the treatment of nonmetastatic crpc
-
6:50
ep. 6: identifying nonmetastatic crpc
-
4:36
nonmetastatic crpc: considerations for apalutamide
-
6:51
understanding nonmetastatic crpc: an overview
-
1:48
dr. bradley on impact of spartan and prosper in nonmetastatic crpc
-
1:13
dr. dorff on parp inhibitors in prostate cancer
-
1:23
dr. bryce on treatment selection in nonmetastatic castration-resistant prostate cancer
-
2:09
dr. hwang on choosing agents for prostate cancer treatment
-
1:19
nonmetastatic crpc: meeting an unmet need
-
0:44
dr. wise on the fda approval of apalutamide in non-metastatic crpc
-
0:47
tanya dorff, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc